Summary

Japan Personalized Medicine Market Research Report By Product Outlook (Personalized Medicine Diagnostics, Personalized Medicine Therapeutics, Personalized Medical Care, Personalized Nutrition and Wellness), By Application Outlook (Oncology, CNS, Immunology, Respiratory, Others) and By End-User Outlook (Hospitals, Diagnostic Centers, Research Academic Institutes, Others) -Forecast to 2035

Market Summary:
As per Market Research Future analysis, the Japan personalized medicine market size was estimated at 29.84 USD Billion in 2024. The Japan personalized medicine market is projected to grow from 31.71 USD Billion in 2025 to 58.26 USD Billion by 2035, exhibiting a compound annual growth rate (CAGR) of 6.2% during the forecast period 2025 - 2035

Market Drivers:
Government initiatives aimed at promoting personalized medicine are significantly impacting the market in Japan. The Japanese government has launched several programs to support research and development in this field, allocating substantial funding to projects that focus on personalized healthcare solutions. For instance, recent budgets indicate an increase of 15% in funding for biotechnology research, which includes personalized medicine initiatives. These efforts are designed to enhance the country's competitiveness in the global healthcare landscape. Additionally, regulatory frameworks are being established to facilitate the approval of personalized therapies, thereby encouraging investment from both domestic and international pharmaceutical companies. This supportive environment is likely to accelerate the growth of the personalized medicine market in Japan. The increasing prevalence of chronic diseases in Japan is driving the demand for targeted therapies within the personalized medicine market. As healthcare providers seek more effective treatment options, the focus on therapies tailored to individual genetic profiles is becoming paramount.

Market Segment Analysis:
The Japan Personalized Medicine Market is experiencing notable growth, particularly within the Product Outlook segment, which encompasses various crucial categories that cater to individual healthcare needs. This segment plays a key role in the overall healthcare landscape, responding to the rising demand for tailored medical solutions that align with patients' unique genetic and phenotypic profiles. Personalized Medicine Diagnostics reflects the importance of precision testing methodologies that enable healthcare providers to assess diverse patient conditions effectively. This increasingly prominent aspect in Japan's market enhances the accuracy of disease diagnosis and facilitates the early detection of health issues, ensuring more effective management strategies for patients. The Application Outlook segment of the Japan Personalized Medicine Market plays a crucial role in shaping the future of healthcare within the region.

Regional Analysis:
The personalized medicine market is experiencing notable growth, driven by advancements in genomics and biotechnology. In Japan, the integration of personalized approaches into healthcare is becoming increasingly prevalent, as healthcare providers recognize the potential for tailored treatments to improve patient outcomes. This shift is supported by government initiatives aimed at fostering innovation in medical research and development. Furthermore, the aging population in Japan is likely to amplify the demand for personalized therapies, as chronic diseases become more common. As a result, stakeholders in the healthcare sector are investing in technologies that enable precision medicine, which may lead to more effective and efficient treatment options.

Major Players:
The following companies are key participants in the Japan Personalized Medicine Market, playing a crucial role in market development through technological innovation, strategic partnerships, and competitive product offerings.

ページTOPに戻る

Table of Contents

TABLE OF CONTENT
1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
EXECUTIVE SUMMARY
Market Overview
Key Findings
Market Segmentation
Competitive Landscape
Challenges and Opportunities
Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
MARKET INTRODUCTION
Definition
Scope of the study
Research Objective
Assumption
Limitations
RESEARCH METHODOLOGY
Overview
Data Mining
Secondary Research
Primary Research
Primary Interviews and Information Gathering Process
Breakdown of Primary Respondents
Forecasting Model
Market Size Estimation
Bottom-Up Approach
Top-Down Approach
Data Triangulation
Validation
3 SECTION III: QUALITATIVE ANALYSIS
MARKET DYNAMICS
Overview
Drivers
Restraints
Opportunities
MARKET FACTOR ANALYSIS
Value chain Analysis
Porter's Five Forces Analysis
Bargaining Power of Suppliers
Bargaining Power of Buyers
Threat of New Entrants
Threat of Substitutes
Intensity of Rivalry
COVID-19 Impact Analysis
Market Impact Analysis
Regional Impact
Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
Japan Personalized Medicine Market SegmentationPersonalized Medicine Product Outlook (USD Billion, 2018-2032)Personalized Medicine DiagnosticsPersonalized Medicine TherapeuticsPersonalized Medical CarePersonalized Nutrition and WellnessPersonalized Medicine Application Outlook (USD Billion, 2018-2032)OncologyCNSImmunologyRespiratoryOthersPersonalized Medicine End-User Outlook (USD Billion, 2018-2032)HospitalsDiagnostic CentersResearch & Academic InstitutesOthersPersonalized Medicine SECTION V: COMPETITIVE ANALYSIS
Competitive Landscape
Overview
Competitive Analysis
Market share Analysis
Major Growth Strategy in the personalized medicine market
Competitive Benchmarking
Leading Players in Terms of Number of Developments in the personalized medicine market
Key developments and growth strategies
New Product Launch/Service Deployment
Merger & Acquisitions
Joint Ventures
Major Players Financial Matrix
Sales and Operating Income
Major Players R&D Expenditure. 2023
Company Profiles
Takeda Pharmaceutical Company Limited
Financial Overview
Products Offered
Key Developments
SWOT Analysis
Key Strategies
Astellas Pharma Inc.
Financial Overview
Products Offered
Key Developments
SWOT Analysis
Key Strategies
Roche Diagnostics K.K.
Financial Overview
Products Offered
Key Developments
SWOT Analysis
Key Strategies
Daiichi Sanky
Company Limited
Financial Overview
Products Offered
Key Developments
SWOT Analysis
Key Strategies
Eisai Co., Ltd.
Financial Overview
Products Offered
Key Developments
SWOT Analysis
Key Strategies
Mitsubishi Tanabe Pharma Corporation
Financial Overview
Products Offered
Key Developments
SWOT Analysis
Key Strategies
Chugai Pharmaceutical Co., Ltd.
Financial Overview
Products Offered
Key Developments
SWOT Analysis
Key Strategies
Kyowa Kirin Co., Ltd.
Financial Overview
Products Offered
Key Developments
SWOT Analysis
Key Strategies
Financial Overview
Products Offered
Key Developments
SWOT Analysis
Key Strategies
Financial Overview
Products Offered
Key Developments
SWOT Analysis
Key Strategies
Appendix
References
Related Reports

COMPANIES MENTIONED
Takeda Pharmaceutical Company Limited, Astellas Pharma Inc., Roche Diagnostics K.K., Daiichi Sankyo Company Limited, Eisai Co., Ltd., Mitsubishi Tanabe Pharma Corporation, Chugai Pharmaceutical Co., Ltd., Kyowa Kirin Co., Ltd.

ページTOPに戻る

List of Tables/Graphs

LIST OF FIGURES
FIGURE 1 MARKET SYNOPSIS
FIGURE 2 JAPAN PERSONALIZED MEDICINE MARKET ANALYSIS BY PRODUCT
FIGURE 3 JAPAN PERSONALIZED MEDICINE MARKET ANALYSIS BY APPLICATION
FIGURE 4 JAPAN PERSONALIZED MEDICINE MARKET ANALYSIS BY END-USER
FIGURE 5 KEY BUYING CRITERIA OF PERSONALIZED MEDICINE MARKET
FIGURE 6 RESEARCH PROCESS OF MRFR
FIGURE 7 DRO ANALYSIS OF JAPAN PERSONALIZED MEDICINE MARKET
FIGURE 8 DRIVERS IMPACT ANALYSIS: JAPAN PERSONALIZED MEDICINE MARKET
FIGURE 9 RESTRAINTS IMPACT ANALYSIS: JAPAN PERSONALIZED MEDICINE MARKET
FIGURE 10 SUPPLY / VALUE CHAIN: JAPAN PERSONALIZED MEDICINE MARKET
FIGURE 11 JAPAN PERSONALIZED MEDICINE MARKET, BY PRODUCT, 2024 (% SHARE)
FIGURE 12 JAPAN PERSONALIZED MEDICINE MARKET, BY PRODUCT, 2024 TO 2035 (USD Billion)
FIGURE 13 JAPAN PERSONALIZED MEDICINE MARKET, BY APPLICATION, 2024 (% SHARE)
FIGURE 14 JAPAN PERSONALIZED MEDICINE MARKET, BY APPLICATION, 2024 TO 2035 (USD Billion)
FIGURE 15 JAPAN PERSONALIZED MEDICINE MARKET, BY END-USER, 2024 (% SHARE)
FIGURE 16 JAPAN PERSONALIZED MEDICINE MARKET, BY END-USER, 2024 TO 2035 (USD Billion)
FIGURE 17 BENCHMARKING OF MAJOR COMPETITORS

LIST OF TABLES
LIST OF ASSUMPTIONS
Japan PERSONALIZED MEDICINE MARKET SIZE ESTIMATES; FORECAST
TABLE 1 BY PRODUCT, 2026-2035 (USD Billion)
TABLE 2 BY PRODUCT, 2026-2035 (USD Billion)
TABLE 3 BY APPLICATION, 2026-2035 (USD Billion)
TABLE 4 BY APPLICATION, 2026-2035 (USD Billion)
TABLE 5 BY END-USER, 2026-2035 (USD Billion)
TABLE 6 BY END-USER, 2026-2035 (USD Billion)
PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
ACQUISITION/PARTNERSHIP